Table 2. PrEP use among participants.
Question | Response | N = 140 |
---|---|---|
Are you currently using the 2-1-1 PrEP dosing method?, N (%) | ||
Yes | 107 (76.4) | |
No | 33 (23.6) | |
Why have you decided to switch from once-daily oral PrEP to on-demand oral PrEP?, N (%) | ||
Because I am having sex less frequently | 89 (63.6) | |
Because I want to take fewer pills | 65 (46.4) | |
Because I want to reduce the cost of my pills | 31 (22.1) | |
Because I want fewer side effects | 27 (19.3) | |
Because my partner(s) changed | 6 (4.3) | |
Other | 4 (2.9) | |
In the past 3 months, how many times have you taken on-demand dosing?, N (%) | ||
0 | 16 (11.4) | |
1–2 | 58 (41.4) | |
3–4 | 39 (27.9) | |
5 or greater | 26 (18.6) | |
No response | 1 (0.7) | |
In the past 3 months, how frequently did you remember to take the double-dose 24 hours before your sexual encounter?a, N (%) | ||
Never–Rarely | 7 (5.7) | |
Sometimes | 12 (9.8) | |
Often–Always | 104 (84.6) | |
In the past 3 months, on average, how many hours before your sexual encounter did you take your double-dose?a, N (%) | ||
0–1 | 9 (7.3) | |
2–5 | 76 (61.8) | |
6–10 | 16 (13.0) | |
11–15 | 6 (4.9) | |
16–20 | 5 (4.1) | |
21–24 | 11 (8.9) | |
In the past 3 months how frequently did you remember to take your single dose 24 hours after the double-dose?a, N (%) | ||
Never–Rarely | 1 (0.8) | |
Sometimes | 7 (5.7) | |
Often–Always | 113 (91.9) | |
No response | 2 (1.6) | |
In the past 3 months how frequently did you remember to take your single dose 48 hours after the double-dose?a, N (%) | ||
Never–Rarely | 3 (2.4) | |
Sometimes | 8 (6.5) | |
Often–Always | 111 (90.2) | |
No response | 1 (0.8) | |
How confident do you feel about the effectiveness of on-demand PrEP versus once-daily PrEP?, N (%) | ||
2-1-1 PrEP is less effective than once-daily PrEP | 18 (12.9) | |
2-1-1 PrEP is as effective as once-daily PrEP | 102 (72.9) | |
2-1-1 PrEP is more effective compared to once-daily PrEP | 2 (1.4) | |
No response | 18 (12.9) | |
What are some strategies that have helped you remember your 2-1-1 doses?, N (%) | ||
Use an alarm either on your cell phone or a clock | 53 (37.9) | |
Take medication after a certain daily activity (such as brushing your teeth or eating breakfast) | 40 (28.6) | |
Use pillbox (or medi-set) | 28 (20.0) | |
Use an application on your cell phone | 17 (12.1) | |
Writing a note to yourself | 16 (11.4) | |
Other | 13 (9.3) | |
Which of the following healthcare team members would you feel comfortable talking to about 2-1-1 PrEP?, N (%) | ||
Provider (Physician, Nurse Practitioner, Physician Assistant) | 110 (78.6) | |
PrEP Navigator | 96 (68.6) | |
Nurse | 92 (65.7) | |
Case Manager or Social Worker | 64 (45.7) | |
Pharmacist | 63 (45.0) | |
Peer Navigator | 47 (33.6) | |
What barriers have you experienced with the 2-1-1 dosing strategy?, N (%) | ||
Unplanned sexual encounters (i.e., missing the double dose 2–24 hours before a sexual encounter) | 61 (43.6) | |
Trouble remembering the dosing schedule after the double dose (i.e., at 24 and 48 hours after the double dose) | 41 (29.3) | |
Lack of healthcare provider knowledge about 2-1-1 dosing | 33 (23.6) | |
Cost associated with prescription and lack of insurance coverage | 22 (15.7) | |
Stigma | 13 (9.3) | |
Alcohol/drug use or mental health challenges | 8 (5.7) | |
Other | 6 (4.3) | |
What challenges have you encountered related to your PrEP medication within the past month?b, N (%) | ||
Lab tests | 27 (25.5) | |
Refills | 20 (18.9) | |
No appointments available | 18 (17.0) | |
Communication with your medical provider | 12 (11.3) | |
I haven’t experienced challenges | 60 (56.6) | |
How has your city’s new Coronavirus policies affected how you seek out romantic or sexual partners?b, N (%) | ||
Completely stopped sexual encounters | 40 (37.7) | |
Exclusively meeting with previous or known partners | 23 (21.7) | |
Having sex less frequently and with caution | 18 (17.0) | |
Unaffected by policies | 12 (11.3) | |
Sharing online content (messages, photos, and videos) | 10 (9.4) | |
No response | 3 (2.8) |
aN = 123.
bN = 106 (during shelter-in-place due to the SARS-CoV-2 pandemic).